Success Metrics

Clinical Success Rate
62.5%

Based on 5 completed trials

Completion Rate
63%(5/8)
Active Trials
5(28%)
Results Posted
0%(0 trials)
Terminated
3(17%)

Phase Distribution

Ph phase_2
3
17%
Ph phase_1
1
6%
Ph phase_4
1
6%
Ph phase_3
3
17%
Ph not_applicable
5
28%

Phase Distribution

1

Early Stage

3

Mid Stage

4

Late Stage

Phase Distribution13 total trials
Phase 1Safety & dosage
1(7.7%)
Phase 2Efficacy & side effects
3(23.1%)
Phase 3Large-scale testing
3(23.1%)
Phase 4Post-market surveillance
1(7.7%)
N/ANon-phased studies
5(38.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

62.5%

5 of 8 finished

Non-Completion Rate

37.5%

3 ended early

Currently Active

5

trials recruiting

Total Trials

18

all time

Status Distribution
Active(6)
Completed(5)
Terminated(3)
Other(4)

Detailed Status

Recruiting5
Completed5
unknown4
Terminated3
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
18
Active
5
Success Rate
62.5%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (7.7%)
Phase 23 (23.1%)
Phase 33 (23.1%)
Phase 41 (7.7%)
N/A5 (38.5%)

Trials by Status

terminated317%
recruiting528%
completed528%
not_yet_recruiting16%
unknown422%

Recent Activity

Clinical Trials (18)

Showing 18 of 18 trials
NCT07542171

Clinical Outcomes After Non-curative Endoscopic Resection in Early Colorectal Cancer: A Multicenter Study

Recruiting
NCT07288034Phase 2

Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Recruiting
NCT04703101Phase 1

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

Recruiting
NCT07074756Not Applicable

A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma

Recruiting
NCT04055220Not Applicable

Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas

Recruiting
NCT02512367Not Applicable

Evaluate the Efficacy of a Global Dental Health Promotion Program on Dental Hygiene in Patients With Schizophrenia.

Terminated
NCT06942663Phase 2

Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Gastric Cancer

Not Yet Recruiting
NCT01558427Phase 2

Non-systemic Treatment for Patients With Low-volume Metastatic Prostate Cancer

Completed
NCT03117816Phase 3

ENDURE - Efficacy and Safety of AOP2014 With CML Patients in Remission

Completed
NCT04184336

Enhanced Population-based Core Surveillance of Meningococcal Invasive Infections at Participating Centers Across Canada

Unknown
NCT03194516

Ketogenic Diet and Prostate Cancer Surveillance Pilot

Completed
NCT01993979Phase 3

A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)

Unknown
NCT03753802Not Applicable

Evaluation of the Effects of Respiratory Physiotherapy in Infants With Moderate Acute Bronchiolitis

Unknown
NCT00118573Phase 4

Comparison of Surveillance Versus Aortic Endografting for Small Aneurysm Repair

Terminated
NCT02576080Phase 3

Efficacy of Imatinib in Patients With Intermediate-risk Gastrointestinal Stromal Tumor With a High-risk Genomic Grade Index

Unknown
NCT01889589

NYC Heart Follow-Up Study 2010

Completed
NCT00428051

Colombia Epidemiologic Surveillance Study

Terminated
NCT00998998Not Applicable

The Anemia Control Program: Early Intervention

Completed

All 18 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
18